About Technology Issues FAQ

Links

A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours

A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.